Mingot-Castellano, M., Reguera, J. L., Zafra Torres, D., Hernani, R., López-Godino, O., Direito de Morais Guerreiro, M. N., . . . Filaferro, S. (2024). Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.
Citación estilo ChicagoMingot-Castellano, Maria-Eva, Juan Luis Reguera, Denis Zafra Torres, Rafael Hernani, Oriana López-Godino, Manuel Nuno Direito de Morais Guerreiro, Pascual Balsalobre, y Silvia Filaferro. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. 2024.
Cita MLAMingot-Castellano, Maria-Eva, et al. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. 2024.